In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
MSK medical oncologist Jonathan Rosenberg, who treats bladder cancer.
Powerful New Bladder Cancer Treatments: Antibody-Drug Conjugates and Checkpoint Inhibitors

Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.
Paige Arnold working in a lab
2022 GSK Chairman’s Prize Celebrates Research That Sheds Light on Cellular Metabolic Processes

Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.
Q&A
Sandra Brennan with a patient
Dense Breast Tissue & Cancer Risk: What You Should Know

In this Q&A, MSK radiologist Sandra Brennan discusses what is known about the link between breast density and cancer risk.
MSK Kids patient Rihanna Plaza
Thanks to MSK's Expertise in Pediatric Cancer Genomics, Rihanna Goes to Kindergarten

Prognosis for Rihanna’s cancer with an NTRK gene mutation improved with larotrectinib, a targeted therapy.
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
MSK Researchers Discover How Cancer Cells Change Identity To Escape Therapies

Researchers learn how prostate cancer cells change their type to survive treatment.
Feature
A bowl of ginseng root sitting next to a teapot.
Natural Remedies for Dry Mouth (Xerostomia)

Discover some natural remedies for mouth dryness (xerostomia) and mouth sores, common side effects of cancer treatment.
Finding
Two chimpanzees in a field
Cancer Genes in Humans vs. Chimps: Why Are We More Susceptible?

In an unusual collaboration, scientists from MSK and the American Museum of Natural History looked at how the BRCA2 gene differs between humans and chimps. Mutations in this gene are linked to an increased risk of certain cancers, including breast cancer.
Q&A
physiatrist Jesuel Padro-Guzman
Answers to 8 FAQ About Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
In the Lab
Scott Lowe
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’

Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA

The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.